Growth Metrics

Kraig Biocraft Laboratories (KBLB) Non-Current Debt (2018 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Non-Current Debt for 7 consecutive years, with $44952.0 as the latest value for Q3 2022.

  • Quarterly Non-Current Debt fell 59.22% to $44952.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $44952.0 through Sep 2022, down 59.22% year-over-year, with the annual reading at $95244.0 for FY2021, N/A changed from the prior year.
  • Non-Current Debt hit $44952.0 in Q3 2022 for Kraig Biocraft Laboratories, down from $59952.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $322000.0 in Q4 2018 to a low of $44952.0 in Q3 2022.
  • Historically, Non-Current Debt has averaged $145802.8 across 4 years, with a median of $120244.0 in 2021.
  • Biggest YoY gain for Non-Current Debt was 50.14% in 2022; the steepest drop was 59.22% in 2022.
  • Year by year, Non-Current Debt stood at $322000.0 in 2018, then crashed by 37.25% to $202044.0 in 2019, then crashed by 52.86% to $95244.0 in 2021, then crashed by 52.8% to $44952.0 in 2022.
  • Business Quant data shows Non-Current Debt for KBLB at $44952.0 in Q3 2022, $59952.0 in Q2 2022, and $62622.0 in Q1 2022.